Compugen | CGEN - Ebitda

Preço das Ações
700.90
Mudança Diária
45.10 6.88%
Mensal
8.75%
Anual
48.21%
Q2 Previsão
636.32




Ebitda Alterar Data
Arca Biopharma USD -25.07M 5.23M 2025-03
aTyr Pharma USD 25.85M 52.43M 2025-12
Bio Path USD -3.21M 631K 2025-03
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -7.89M 536K 2025-09
Immunic USD -22.78M 753K 2024-06
Infinity Pharmaceuticals USD -10.01M 1.39M 2023-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
RedHill Biopharma USD 2.69M 108.46M 2023-06
TherapeuticsMD USD -1.64M 700K 2023-09